Prognostic Factors for Survival in Hepatocellular Carcinoma

Cancer Research

Volumn 48, Issue , 1988, Pages 7314-7318

  Falkson, Geoffrey ^a   Cnaan, Avital ^a   Schutt, Allan J ^c   Ryan, Louise M ^b,c   Falkson, Hendrika C ^d  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; SEMUSTINE;

AGE; ETHNIC OR RACIAL ASPECTS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; SOUTH AFRICA; UNITED STATES;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGE; PROGNOSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024244434     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Cook, G. G. Hepatocellular carcinoma: one of the world's most common malignancies. Q. J. Med., 233:705-708,1985.
2. Dunham, L. J., and Bailar, J. C., III. World maps of cancer mortality rates and frequency ratios. J. Natl. Cancer Inst., 41:155-203, 1968.
3. Silverberg, E. Cancer statistics 1985. Ca Cancer J. Clin., 35: 19–35, 1985.
4. Geddes, E. W., and Falkson, G. Malignant hepatoma in the Bantu. Cancer (Phila.), 25:1271-1278,1970.
5. Attali, P., Prod’Homme, S., Pelletier, G.,et al. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival. Cancer (Phila.), 59:2108-2111,1987.
6. Pocock, S. J. Clinical Trials: A Practical Approach. New York: John Wiley, 1983.
7. Okuda, K., and the Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer (Phila.), 45:2663-2669,1980.
8. Chlebowski, R., Tong, M., Weissman, J.,et al. Hepatocellular carcinoma—diagnostic and prognostic features in North American patients. Concer (Phila.), 53:2701-2706,1984.
9. Ihde, D., Matthews, M., Makuch, R., Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy—identification of two groups of patients with prospects for prolonged survival. Am. J. Med., 78:399-406,1985.
10. Sutton, F. M., Russell, N. C., Guinee, V. F., Factors affecting the prognosis of primary liver carcinoma. J. Clin. Oncol., 6:321-328,1988.
11. Nerenstone, S. R., Ihde, D. C., and Friedman, M. A. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat. Rev., 15:1-31,1988.
12. Falkson, G., MacIntyre, J. M., Moertel, C. G., Primary liver cancer. An Eastern Cooperative Oncology Group trial. Cancer (Phila.), 54:970-971, 1984.
13. Falkson, G., Moertel, C. G., Lavin, P., Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial. Cancer (Phila.), 42: 2149-2156,1978.
14. Falkson, G., MacIntyre, J. M., Schutt, A. J., Neocarzinostatin versus m-amsa or doxorubicin in hepatocellular carcinoma. J. Clin. Oncol., 2:581—584,1984.
15. Falkson, G., Ryan, L. M., Johnson, L. A., A random Phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer (Phila.), 60:2141-2145,1987.
16. Mehta, C. R., and Patel, N. R. A network algorithm for Fisher's exact test in r x c contingency tables. J. Am. Stat. Assoc., 78:427-434,1983.
17. Kalbfleisch, J. D., and Prentice, R. L. The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980.
18. Anderson, J. R., Cain, K. C., Gelber, R. D., Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. Cancer Treat. Rep., 69:1139-1144,1985.
19. Okuda, K., Peters, R. L., and Simson, I. W. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer (Phila.), 54: 2165-2173,1984.